Earnings Scheduled For November 3, 2021
Companies Reporting Before The Bell
• R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.
BioCryst Shares Down ~2.5% Ahead Of Co.’s 2 p.m. EDT Presentation At Cantor’s Global Healthcare Conference
https://wsw.com/webcast/cantor12/register.aspx?conf=cantor12&page=bcrx&url=https://wsw.com/webcast/cantor12/bcrx/2084950
NICE Recommends BioCryst’s Hereditary Angioedema Med
The U.K.’s National Institute for Health and Care Excellence (NICE) has recommended BioCryst Pharmaceuticals Inc’s (NASDAQ:BCRX) Orladeyo (berotralstat) for hereditary angioedema…
BioCryst Announces Approval Of ORLADEYO In United Arab Emirates
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that the Ministry of Health and Prevention (MOHAP) in the United Arab Emirates (UAE) has granted marketing authorization for oral, once-daily
The Daily Biotech Pulse: Early Approval For Ascendis’ Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 25)
BioCryst Announces Acceptance of Regulatory Applications for ORLADEYO® (berotralstat) by Health Canada and Swissmedic
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that the new drug submission for ORLADEYO® (berotralstat) has been accepted for review by Health Canada for the prevention of recurrent attacks
‘Benin confirms H5N1 avian flu outbreak’ -Al Jazeera Report
https://www.aljazeera.com/news/2021/8/25/benin-confirms-h5n1-avian-flu-outbreak
Analyzing BioCryst Pharmaceuticals’s Unusual Options Activity
BioCryst Pharmaceuticals (NASDAQ:BCRX) shares experienced unusual options activity on Monday. The stock price moved down to $15.44 following the option alert.
Analyzing BioCryst Pharmaceuticals’s Unusual Options Activity
BioCryst Pharmaceuticals (NASDAQ:BCRX) shares experienced unusual options activity on Wednesday. The stock price moved up to $15.66 following the option alert.